Dysregulation of IGF-2 expression occurs in many other cancers, and IGF-2 is thought to stimulate cancer development via binding to IGF-1 receptors and subsequent activation of the MAPK and PI3-K/Akt pathways.6 The gene discussed is AKT1; the disease is cancer.